SlideShare a Scribd company logo
Tenet’s Q1 2006 Earnings Call Prepared Remarks

                                              May 9, 2006


Trevor Fetter, President & Chief Executive Officer

Thank you, operator, and good morning everyone.

I trust that you’ve had an opportunity to review the press release we issued this morning with our
first quarter results. I’ll start by giving you an overview of the quarter, and then our Chief
Operating Officer, Reynold Jennings, will provide some commentary on volumes.

I hope that you’ve seen our press release regarding the action yesterday evening by the Inspector
General of HHS to exclude our hospital in San Diego from federal health programs. The IG made
that announcement after we had prepared our remarks for this morning, but Peter Urbanowicz, our
General Counsel, and I will be prepared to answer your questions about that matter during our
Q&A.

The predominant themes in the quarter continued to be weak volumes, strong pricing and good
cost control.

Three years ago, we had isolated but severe problems in pricing and clinical quality, and we had
widespread problems in cost control, litigation, investigations, governance, labor relations and
relations with uninsured patients. Since that time, we’ve either resolved, or are far along in
resolving, each one of those issues.

But as we’ve been fixing the original problems, we’ve confronted two new challenges affecting
the entire industry: bad debts and weak volumes. Today, bad debts appear to be stabilizing, while
weak volumes remain our number one concern.

As we worked to resolve the problems that we faced three years ago, we built a solid foundation
for the future. We are fighting the volume challenge with the same energy and creativity that we
brought to the problems we faced at the end of 2002, and our success in these areas demonstrates
that when our team sets out to fix something, we fix it. I am confident that we will do the same
with volumes.

Let me turn to the results for the quarter.

We generated net income from continuing operations of $15 million, or 3 cents per share, and
EBITDA of $216 million for the quarter, for a margin of 8.9 percent.

We use two different metrics to describe results in our earnings release: continuing operations
and same-hospital. Both measures are important, but I’m going to refer primarily to same-


                                                   1
hospital numbers in my comments, as I believe those are the greatest interest to you. Same-
hospital numbers are continuing operations excluding the six hospitals impacted by Hurricane
Katrina. Operations in the Gulf Coast region are still sufficiently impaired that to include them
in the discussion distorts the performance of our core business.

On a same-hospital basis, our EBITDA margin was 9.5 percent, a 50 basis point increase from
last year’s first quarter.

We identified five distinct items in our press release that had a net favorable contribution of $1
million. We broke these out so that you could decide which of these items should be included in
your individual assessments of our current earnings. These items include litigation and
investigation costs, impairment and restructuring charges, costs related to Katrina, our unusual
tax position and favorable adjustments from prior year cost report settlements.

As we have discussed in previous quarters, we also had a reversal of some temporary spikes in
bad debt expense from the last half of ’05, which we estimate added about $5 million, or 1 cent
per share, to earnings this quarter. I’ll take you through the details on bad debt trends in just a
few minutes.

As you know, the first quarter is typically our strongest of the year. The 3 cents we earned from
continuing operations is above the consensus estimates for the quarter, but at this point, we are
not going to refine or confirm the outlook for 2006 that we issued in March. Our practice has
been to issue an outlook only once a year, and after only one quarter it would be premature to
refine or confirm it.

Drilling down into the specifics of the quarter, let’s start with volumes. The decline in volumes
drives the outcome of virtually every other performance metric, and starting with volumes is the
only way to place the quarter’s results in context.

Same-hospital admissions declined by 3.3 percent relative to last year’s first quarter. Nearly a
third of the decline results from the deliberate elimination of service lines or operating entities.
The more serious impact on earnings came from the 5.3 percent decline in same-hospital
commercial managed care volumes.

Our acuity rose by one and a quarter percent from last year’s first quarter, and by more than a
half a percent from Q405. This was driven by increases in acuity in several of our service lines.
In cardiology, we had volume losses in the less intense procedures. Cardiology volume was
down 5 percent, but case mix was flat. In orthopedic and spine surgery, volumes were up by
nearly 3 percent and case mix was up 2 percent. In pulmonary medicine, volume was down by 6
percent, but case mix was up by 6 percent. And in general surgery, volume was down by 4
percent and case mix was up 2 percent. These were the drivers of the increase in acuity for the
quarter.

Let’s turn to pricing, where we achieved very strong results for the third consecutive quarter.
We recorded a 7.7 percent increase in same-hospital, Compact-adjusted net inpatient revenue per
admission. On the outpatient side, the comparable metric increased by 11.9 percent. While the


                                                  2
increase in acuity helped slightly, these aggregate increases are especially impressive as they
helped offset the adverse shift in our payor mix away from commercial managed care patients
and toward managed Medicare and Medicaid.

The real strength becomes visible when we narrow our focus to just the commercial managed
care piece of our business. For commercial managed care, net inpatient revenue per admission
increased by 11.8 percent on a same-hospital basis. Our managed care team has done an
excellent job of fixing our pricing problems and putting our hospitals on solid ground in pricing
and contract terms. The missing piece is volume, and that’s why Tenet’s profit growth is
critically dependent on volume growth. When we rebuild commercial managed care volumes,
these impressive pricing gains will be reflected on the bottom line.

If we had generated the same commercial managed care volumes in the first quarter of 2006 as in
the first quarter of 2005, we would have retained additional revenues of about $50 million with
50 to 60 percent of that adding to EBITDA for the quarter. We estimate that retaining the
managed care volume we lost over the past year would have added 110 to 125 basis points to our
EBITDA margin.

Despite the recent declining volumes in commercial managed care, our aggregate portfolio yield
on our inpatient business increased by 6.1 percent compared to the first quarter of 2005. You
will recall that in our fourth quarter, we reported a year-over-year increase of 9.7 percent for our
aggregate portfolio yield; so on a sequential basis, our improvement moderated a bit. We expect
the moderation to continue as we reach the anniversary of some of these strong quarters.

These pricing increases offset the volume declines to create 3.1 percent growth in revenues on a
same-hospital, Compact-adjusted basis.

We also continued to do a great job on cost control. Same-hospital controllable costs per
adjusted patient day actually declined by 2.8 percent from Q405 to Q106.

On a year-over-year basis, our controllable operating expense per adjusted patient day rose by
5.2 percent. Not surprisingly, the line item with the greatest increase was supply expense, which
increased 6.2 percent.

Despite a comparatively more severe decline in volumes, our growth rate in unit controllable
costs of 5.2 percent is below our peers and further demonstrates the favorable impact of our
discipline in cost control, which is now hard-wired throughout the company. Given what we’ve
accomplished in pricing and costs, we’ve set the stage for strong growth in income when we
generate growth in volumes.

Let’s move on to bad debt.

On a same-hospital, Compact-adjusted basis, our bad debt ratio was 12.9 percent for the quarter,
an increase of 110 basis points from a year ago, but a decline of 140 basis points from the 14.3
percent that we reported last quarter.




                                                 3
You will recall that in the past two quarters we isolated the impact of some systems conversion
issues, which caused a temporary increase in bad debt expense. We told you that as we collected
these delayed billings, we expected our bad debt ratio to show a temporary decline, reversing the
earlier increase. This quarter we collected the remainder of these amounts, which reduced the
first quarter’s bad debt ratio by roughly 20 basis points, adding an estimated $5 million to
EBITDA.

Another trend in bad debt was that more of our uninsured patients were classified as “charity.”
In part, this is due to the elimination of the adult medically indigent program in Tennessee and
the elimination of funding for undocumented immigrants in the California county where Doctors
Medical Center of Modesto is located. The elimination or reduction of similar funds in Missouri
and Georgia will continue to limit the uninsured, low income population from eligibility and
further increase our charity care.

I am highlighting this growth in charity partly because I don’t want anyone to conclude that we
are making more progress on reducing bad debt than is actually the case. The other reason to
highlight this change is to follow up on my comments last quarter about cost-shifting. Last
quarter, I talked about cost-shifting from employer to employee. Well, here’s another stark
example of cost shifting: state and county governments simply deciding not to compensate
hospitals for the care that we are providing to their residents, whom we have a federal mandate to
care for. I think it’s outrageous, and you’ve got to wonder when this situation is going to reach a
breaking point.

The number of charity inpatients increased by 30 percent from last year’s first quarter, on a
same-hospital basis to over 2,800 patients. Total uncompensated inpatient care volume, defined
as uninsured self pay and charity, rose 8 percent on a same-hospital basis since the first quarter
of last year. It’s a rough estimate, but we think that the total uncompensated care that we provide
these people is costing us about a quarter billion dollars per year. That’s cost, not charges or
foregone revenues, which of course, would be considerably higher.

Since hospitals are the primary sector of the health care economy that is bearing the
responsibility for these costs, again I’ve got to ask the question of when this situation reaches a
breaking point and gains sufficient attention in federal, state and local governments.

We also had a very active quarter on the quality front. The major national managed care
companies recognized Tenet’s advances in quality by continuing to award our hospitals’ Centers
of Excellence designations for an ever-growing number of service lines.

Last quarter, we spoke in great detail about the UnitedHealth Care designations. This quarter,
I’d like to spend some time telling you about our Cigna designations.

Cigna’s policy is to re-evaluate all service line designations on an annual basis. This year, they
expanded the number of service lines to 29 from 19, while simultaneously raising the volumes
required to be eligible.




                                                  4
In 2005, 41 Tenet hospitals earned 95 service line designations as Centers of Excellence from
Cigna. As of today, Tenet hospitals had achieved a 56 percent increase in Centers of Excellence
designations, bringing our total Cigna designations to 149. To receive these designations
requires the hospitals to receive 3 stars from Cigna on both patient outcomes and cost efficiency,
offering significant advantages to both the patient and the payor.

In addition to these designations, 11 of our hospitals were named Cigna Certified Hospitals for
Bariatric Surgery. Because Cigna awarded only 88 of these certifications across the country,
Tenet’s hospitals represent one-eighth of the national total. We hope that these certifications,
along with the government’s recent decision to cover some bariatric procedures, will influence
other payors to cover these surgeries going forward.

We’ve got a number of initiatives to improve quality and grow volume. Our efforts to gain these
Centers of Excellence designations are at the heart of these strategies.

To benefit from the cost efficiencies associated with these designations, some of the managed
care payors are offering to reduce deductibles or eliminate co-pays. When you factor these
incentives into the equation, the ability to link quality and efficiency to higher patient volumes
becomes very real and very exciting.

Two and a half years ago, I declared that quality would be our strategy because it was the right
thing to do. Period. But as these quality designations and plan designs intersect with
consumerism, Tenet’s investments in quality should show greater economic returns as well.

Let’s now turn to cash flow.

Cash flow used by operating activities was negative $321 million in the quarter. Including
capital expenditures of $117 million, free cash flow was negative $438 million.

While our cash consumption was large, it’s important to note that there were several unusual
items adversely impacting cash this quarter:

First, payments toward restructuring, litigation costs and settlements, and discontinued
operations totaled $183 million. This includes a $145 million payment to settle a securities class
action lawsuit and a $7 million payment to settle with Florida’s attorney general.

Second, we paid $97 million in the quarter to fund the entire 2005 401(k) matching
contributions. This is substantially more than we paid a year ago because the Q105 funding
represented only half the total 2004 contribution. We decided to change the timing of our
funding in May 2004 for contributions for the period beginning July 1, 2004, which were then
funded in the first quarter of 2005. We made this change to reduce costs and we estimate this
change will save us nearly $15-20 million annually, due to employee turnover and eligibility.

Third, our interest payments on long-term debt were $123 million. There were additional
payments of $29 million this quarter compared to the prior year due to the additional debt that
we issued in January 2005 and the timing of our interest payments.


                                                 5
The first quarter typically has a high cash burn, given the timing of our expenditures. If you look
at 2005, for example, you’ll see that cash flow improved in subsequent quarters during the year.

Unrestricted net cash at the end of March was $975 million. In addition, we had another $263
million in cash that’s restricted as collateral for standby letters of credit.

Now, before I turn the floor over to Reynold, I’d like to call your attention to a series of
organizational changes that we’ve made over the past few weeks. We appointed one of our
senior operations executives to lead a group to execute our outpatient growth strategy. We also
restructured our regional operations in Florida and the Southern States to better enable our
regional leaders to focus on local market business development. I’m proud that we have been
able to retain and recognize talented people from within the organization, and we’ve been able to
recruit fresh talent from other fine companies.

With that as an overview, let me turn things over to Reynold for a deeper look at some of the
volume building efforts underway in our hospitals.


Reynold Jennings, Chief Operating Officer

Thanks Trevor, and good morning.

I’d like to begin by commenting on Tenet’s inpatient volumes in the first quarter. As Trevor
mentioned, we saw a continuation of the aggregate volume decline we’ve experienced in recent
quarters. Embedded in these numbers, however, is a more complex and positive story.

Fifteen of our hospitals actually had strong year-over-year growth in patient volumes. And 11
more had volumes about even with their first-quarter results last year. In other words, 26
hospitals – or about 40 percent of our portfolio – delivered reasonably good results in the quarter.
The hospitals with the strongest growth were in Birmingham, Atlanta, Omaha, St. Louis,
Memphis, the Carolinas and parts of Florida. Since many of these are historically among our
strongest margin hospitals, we see this as good news.

On the other side of the coin, 14 of our hospitals – or about 20 percent of the portfolio –
accounted for about 90 percent of our aggregate, year-over-year decline in volumes. This group
included hospitals in Florida, California and Texas. Let me give you some detail about what
affected these hospitals in the quarter:

A. In Florida, the combination of a warm winter in the Northeast, and extensive damage from
   Hurricane Wilma seriously reduced tourism in the state, as well as the number of snowbirds
   who usually spend the winter there. These factors, along with a weaker than normal flu
   season, resulted in fewer admissions at five of our Florida hospitals. Also, hurricane damage
   to condo projects forced some, mostly elderly residents who live in the communities served
   by two of our hospitals, to find temporary housing outside the area. However, we believe
   that situation will reverse itself shortly.


                                                 6
B. In California, our targeted growth initiative’s planned de-emphasis of certain service lines
   accounted for about half of the volume decline there. We attribute the other half to our
   decision at two California hospitals to reject the unacceptably low capitation rates in a new
   contract offered by two large medical groups.

C. In Texas, two hospitals we lease in Dallas accounted for 24 percent of the volume decline in
   that state. Business at those hospitals – Trinity and RHD Memorial – has been hurt this year
   by the uncertainty generated after their owner, the Metrocrest Hospital Authority, sought
   competitive bids to manage them once our lease expires in 2007. The balance of our volume
   decline in Texas was primarily the result of stiff competition from four new and maturing
   hospitals in Dallas and Houston.

So, to summarize, I’d say our volume results for the first quarter show that a significant portion
of our portfolio is doing pretty well, especially in light of the general challenges faced by all
hospitals these days. Our overall volume weakness is basically caused by 14 hospitals with very
specific issues, and we are aggressively tackling those situations.

Let me now move to our Physician Sales and Service Program, which we launched last year.
The results continue to be very encouraging. Our hospital management teams have had face-to-
face meetings with about 11,000 of our 13,000 targeted doctors, and as a result, we have
identified about 1,600 individual opportunities for service improvement at our hospitals.

Based on this experience, we’ve learned that there is nothing more positive in building and
cementing relationships with our doctors than asking them to tell us about issues they have with
the hospital and then taking quick action to resolve them. The physicians continue to express
appreciation for the visits by our local hospital management teams and the efforts being made to
respond to their needs.

On our last call, I gave you some examples of the service improvement opportunities we have
identified, all of which fall into three categories: First, those that are easy to understand and
resolve; second, those that can be resolved but will take some time; and thirdly, those for which
we don’t yet have a solution.

Thematically, these opportunities fall into seven broad categories:

1.   Process improvement and throughput
2.   Customer service
3.   Modernization of our physical plants
4.   Marketing/advertising/community outreach
5.   Physician recruitment
6.   Effective communication between hospital administrators and physicians, and
7.   Scheduling, registration and pricing of outpatient services

Some components of our Commitment to Quality initiative are already implementing significant
improvements in critical service areas such as the emergency department and surgery. With the


                                                7
additional information we now have as a result our physician visits, we are focused on improving
others areas within the hospital and also boosting the spirit of collaboration with our physicians.
With regard to boosting that spirit of collaboration, let me give you three rather simple examples:

   •   First, physicians in one of our Houston hospitals told us that our outpatient order forms
       were difficult to use. We immediately worked with the physicians to redesign the forms
       and added carbonless copies to save both time and cost.

   •   Second, physicians in East Texas told us that a specialty group at a competing hospital
       was breaking up, and that gave our hospital leaders the opportunity to recruit two of those
       physicians to our hospital.

   •   And third, we found that the primary care physicians and endocrinologists in our El Paso
       hospitals were looking for educational opportunities in bariatric surgery. They were
       delighted when we quickly gave them copies of our new clinical service manual focused
       specifically on bariatric procedures.

These examples should make it clear that not all physician-friendly improvements need to be
expensive. And, as an indication of how well our hospital managers are embracing the value of
the physician visitation program, I can tell you that our data clearly shows the hospitals with the
greatest volume challenges also happen to be the ones most actively using the program software
tracking tool that we’ve implemented. I’m optimistic that we have much more value to harvest
from this program.

Now let me talk about the operational effect of local hospital management stability. Of the 14
hospitals I spoke of that drove the lion’s share of our aggregate volume decline in the first
quarter, three were being managed by an interim chief executive officer and three others were
being managed by newly hired permanent CEOs.

We lost six experienced hospital CEOs in December 2005, all of whom left because they had
been recruited by larger, well-known hospital systems. I see that loss as a bittersweet
consequence of our accomplishments in public quality scores, cost control and data-enriched
decision making. Tenet’s progress in these and other operational enhancement initiatives have
made many of our hospital executives the target of executive search firms.

We are redoubling our efforts to retain our top talent, and one way we’re doing that is by making
sure our experienced hospital CEOs have a career ladder with us. Fortunately, we have been
able to replace our hospital departing hospital executives with well-qualified internal candidates
in almost half the cases. In addition, our external recruiting efforts have brought us some very
good managers from other companies and hospital systems. I am excited about both the internal
and external candidates’ enthusiasm for being a part of our future.

Before I turn it back over to Trevor, let me mention that at the end of the first quarter we had
virtually completed the latest wave of our targeted growth initiative. This involved eleven
hospitals, including the remaining two in California, five in Florida, two in the Central Northeast,
and two in Texas.


                                                 8
With that, I’ll hand it back over to Trevor.


Trevor Fetter, President & Chief Executive Officer

Thank you Reynold, operator, we are ready now to begin the Q&A.

[END]




                                               9

More Related Content

What's hot

quest diagnostics 4Q07Call_Script
quest diagnostics 4Q07Call_Scriptquest diagnostics 4Q07Call_Script
quest diagnostics 4Q07Call_Script
finance34
 
Barclays global healthcare conference
Barclays global healthcare conferenceBarclays global healthcare conference
Barclays global healthcare conference
impax-labs
 
sovereignbank Q4_2007
sovereignbank Q4_2007sovereignbank Q4_2007
sovereignbank Q4_2007
finance47
 
sovereignbank Q1_2008
sovereignbank Q1_2008sovereignbank Q1_2008
sovereignbank Q1_2008
finance47
 
quest diagnostics 10_20_05
quest diagnostics 10_20_05quest diagnostics 10_20_05
quest diagnostics 10_20_05
finance34
 
United Health Group[PDF Document] Earnings Release
United Health Group[PDF Document] Earnings ReleaseUnited Health Group[PDF Document] Earnings Release
United Health Group[PDF Document] Earnings Release
finance3
 
fifth third bancorp Q4-02
fifth third bancorp  Q4-02fifth third bancorp  Q4-02
fifth third bancorp Q4-02
finance28
 
TE Connectivity Q2 Earnings Presentation
TE Connectivity Q2 Earnings PresentationTE Connectivity Q2 Earnings Presentation
TE Connectivity Q2 Earnings Presentation
TEConnectivityltd
 
Fy17 q1 slides ugi-v_final
Fy17 q1   slides ugi-v_finalFy17 q1   slides ugi-v_final
Fy17 q1 slides ugi-v_final
UGI_Corporation
 
Q2 presentation v4
Q2 presentation v4Q2 presentation v4
Q2 presentation v4
Corning_Owens
 
17 q3 earnings deck v2
17 q3 earnings deck v217 q3 earnings deck v2
17 q3 earnings deck v2
investorsmalibuboats
 
1 q17 presentation final
1 q17 presentation   final1 q17 presentation   final
1 q17 presentation final
aoncorp
 
TE Connectivity Q3 2016 Earnings Presentation
TE Connectivity Q3 2016 Earnings PresentationTE Connectivity Q3 2016 Earnings Presentation
TE Connectivity Q3 2016 Earnings Presentation
TEConnectivityltd
 
Investor update march 2016 website
Investor update march 2016 websiteInvestor update march 2016 website
Investor update march 2016 website
investor_phillips66
 
Q2 presentation v2
Q2 presentation v2Q2 presentation v2
Q2 presentation v2
Corning_Owens
 
General investor presentation september 2017
General investor presentation september 2017General investor presentation september 2017
General investor presentation september 2017
irbgcpartners
 
Fy17 q2 slides ugi-v_final
Fy17 q2   slides ugi-v_finalFy17 q2   slides ugi-v_final
Fy17 q2 slides ugi-v_final
UGI_Corporation
 
Walmart Quarterly Earnings Q3 2009(2)
Walmart Quarterly Earnings Q3 2009(2)Walmart Quarterly Earnings Q3 2009(2)
Walmart Quarterly Earnings Q3 2009(2)
earningsreport
 
Tds usc q1 2017 presentation
Tds usc q1 2017 presentationTds usc q1 2017 presentation
Tds usc q1 2017 presentation
TelephoneDataSystems
 
2 q15 presentation final
2 q15 presentation   final2 q15 presentation   final
2 q15 presentation final
aoncorp
 

What's hot (20)

quest diagnostics 4Q07Call_Script
quest diagnostics 4Q07Call_Scriptquest diagnostics 4Q07Call_Script
quest diagnostics 4Q07Call_Script
 
Barclays global healthcare conference
Barclays global healthcare conferenceBarclays global healthcare conference
Barclays global healthcare conference
 
sovereignbank Q4_2007
sovereignbank Q4_2007sovereignbank Q4_2007
sovereignbank Q4_2007
 
sovereignbank Q1_2008
sovereignbank Q1_2008sovereignbank Q1_2008
sovereignbank Q1_2008
 
quest diagnostics 10_20_05
quest diagnostics 10_20_05quest diagnostics 10_20_05
quest diagnostics 10_20_05
 
United Health Group[PDF Document] Earnings Release
United Health Group[PDF Document] Earnings ReleaseUnited Health Group[PDF Document] Earnings Release
United Health Group[PDF Document] Earnings Release
 
fifth third bancorp Q4-02
fifth third bancorp  Q4-02fifth third bancorp  Q4-02
fifth third bancorp Q4-02
 
TE Connectivity Q2 Earnings Presentation
TE Connectivity Q2 Earnings PresentationTE Connectivity Q2 Earnings Presentation
TE Connectivity Q2 Earnings Presentation
 
Fy17 q1 slides ugi-v_final
Fy17 q1   slides ugi-v_finalFy17 q1   slides ugi-v_final
Fy17 q1 slides ugi-v_final
 
Q2 presentation v4
Q2 presentation v4Q2 presentation v4
Q2 presentation v4
 
17 q3 earnings deck v2
17 q3 earnings deck v217 q3 earnings deck v2
17 q3 earnings deck v2
 
1 q17 presentation final
1 q17 presentation   final1 q17 presentation   final
1 q17 presentation final
 
TE Connectivity Q3 2016 Earnings Presentation
TE Connectivity Q3 2016 Earnings PresentationTE Connectivity Q3 2016 Earnings Presentation
TE Connectivity Q3 2016 Earnings Presentation
 
Investor update march 2016 website
Investor update march 2016 websiteInvestor update march 2016 website
Investor update march 2016 website
 
Q2 presentation v2
Q2 presentation v2Q2 presentation v2
Q2 presentation v2
 
General investor presentation september 2017
General investor presentation september 2017General investor presentation september 2017
General investor presentation september 2017
 
Fy17 q2 slides ugi-v_final
Fy17 q2   slides ugi-v_finalFy17 q2   slides ugi-v_final
Fy17 q2 slides ugi-v_final
 
Walmart Quarterly Earnings Q3 2009(2)
Walmart Quarterly Earnings Q3 2009(2)Walmart Quarterly Earnings Q3 2009(2)
Walmart Quarterly Earnings Q3 2009(2)
 
Tds usc q1 2017 presentation
Tds usc q1 2017 presentationTds usc q1 2017 presentation
Tds usc q1 2017 presentation
 
2 q15 presentation final
2 q15 presentation   final2 q15 presentation   final
2 q15 presentation final
 

Viewers also liked

terex bylaws08
terex bylaws08terex bylaws08
terex bylaws08
finance42
 
tenet healthcare Q108EarningsRemarks
tenet healthcare Q108EarningsRemarkstenet healthcare Q108EarningsRemarks
tenet healthcare Q108EarningsRemarks
finance42
 
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlides
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlidespulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlides
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlides
finance42
 
SLM CorpSupplementalEarnDiscQ406
SLM CorpSupplementalEarnDiscQ406SLM CorpSupplementalEarnDiscQ406
SLM CorpSupplementalEarnDiscQ406
finance42
 
Supplemental2Qtr08BOW63513BOW004_BITS_N
Supplemental2Qtr08BOW63513BOW004_BITS_NSupplemental2Qtr08BOW63513BOW004_BITS_N
Supplemental2Qtr08BOW63513BOW004_BITS_N
finance42
 
tenet healthcare Earn_Rel_2008_Q2_FINAL
tenet healthcare Earn_Rel_2008_Q2_FINALtenet healthcare Earn_Rel_2008_Q2_FINAL
tenet healthcare Earn_Rel_2008_Q2_FINAL
finance42
 
slm W052931620N
slm W052931620Nslm W052931620N
slm W052931620N
finance42
 
KBR_BEKPresentation
KBR_BEKPresentationKBR_BEKPresentation
KBR_BEKPresentation
finance42
 
13_Yonker_Supplies_Final
13_Yonker_Supplies_Final13_Yonker_Supplies_Final
13_Yonker_Supplies_Final
finance42
 
slm annrpt_2000
slm annrpt_2000slm annrpt_2000
slm annrpt_2000
finance42
 
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108dana holdings AuditCommitteeAccountingComplaintsPolicy_013108
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108
finance42
 
SallieMaeFY2005AnnualReport
SallieMaeFY2005AnnualReportSallieMaeFY2005AnnualReport
SallieMaeFY2005AnnualReport
finance42
 
tenet healthcare CY0510QA1JUNFinal
tenet healthcare CY0510QA1JUNFinaltenet healthcare CY0510QA1JUNFinal
tenet healthcare CY0510QA1JUNFinal
finance42
 
terex Compensation08
terex Compensation08terex Compensation08
terex Compensation08
finance42
 
tenet healthcare Q306Earnings1
tenet healthcare  Q306Earnings1tenet healthcare  Q306Earnings1
tenet healthcare Q306Earnings1
finance42
 
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009
finance42
 
tenet healthcare 10K03082005
tenet healthcare 10K03082005tenet healthcare 10K03082005
tenet healthcare 10K03082005
finance42
 
saic annual reports 2004
saic annual reports 2004saic annual reports 2004
saic annual reports 2004
finance42
 
slm 2003proxy
slm 2003proxyslm 2003proxy
slm 2003proxy
finance42
 

Viewers also liked (19)

terex bylaws08
terex bylaws08terex bylaws08
terex bylaws08
 
tenet healthcare Q108EarningsRemarks
tenet healthcare Q108EarningsRemarkstenet healthcare Q108EarningsRemarks
tenet healthcare Q108EarningsRemarks
 
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlides
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlidespulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlides
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlides
 
SLM CorpSupplementalEarnDiscQ406
SLM CorpSupplementalEarnDiscQ406SLM CorpSupplementalEarnDiscQ406
SLM CorpSupplementalEarnDiscQ406
 
Supplemental2Qtr08BOW63513BOW004_BITS_N
Supplemental2Qtr08BOW63513BOW004_BITS_NSupplemental2Qtr08BOW63513BOW004_BITS_N
Supplemental2Qtr08BOW63513BOW004_BITS_N
 
tenet healthcare Earn_Rel_2008_Q2_FINAL
tenet healthcare Earn_Rel_2008_Q2_FINALtenet healthcare Earn_Rel_2008_Q2_FINAL
tenet healthcare Earn_Rel_2008_Q2_FINAL
 
slm W052931620N
slm W052931620Nslm W052931620N
slm W052931620N
 
KBR_BEKPresentation
KBR_BEKPresentationKBR_BEKPresentation
KBR_BEKPresentation
 
13_Yonker_Supplies_Final
13_Yonker_Supplies_Final13_Yonker_Supplies_Final
13_Yonker_Supplies_Final
 
slm annrpt_2000
slm annrpt_2000slm annrpt_2000
slm annrpt_2000
 
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108dana holdings AuditCommitteeAccountingComplaintsPolicy_013108
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108
 
SallieMaeFY2005AnnualReport
SallieMaeFY2005AnnualReportSallieMaeFY2005AnnualReport
SallieMaeFY2005AnnualReport
 
tenet healthcare CY0510QA1JUNFinal
tenet healthcare CY0510QA1JUNFinaltenet healthcare CY0510QA1JUNFinal
tenet healthcare CY0510QA1JUNFinal
 
terex Compensation08
terex Compensation08terex Compensation08
terex Compensation08
 
tenet healthcare Q306Earnings1
tenet healthcare  Q306Earnings1tenet healthcare  Q306Earnings1
tenet healthcare Q306Earnings1
 
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009
 
tenet healthcare 10K03082005
tenet healthcare 10K03082005tenet healthcare 10K03082005
tenet healthcare 10K03082005
 
saic annual reports 2004
saic annual reports 2004saic annual reports 2004
saic annual reports 2004
 
slm 2003proxy
slm 2003proxyslm 2003proxy
slm 2003proxy
 

Similar to TenetQ106PreparedRemarks

tenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarkstenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarks
finance42
 
tenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarkstenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarks
finance42
 
tenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarkstenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarks
finance42
 
TenetQ307PreparedRemarks_Final
TenetQ307PreparedRemarks_FinalTenetQ307PreparedRemarks_Final
TenetQ307PreparedRemarks_Final
finance42
 
tenet healthcare Q308EarningsRemarks
tenet healthcare Q308EarningsRemarkstenet healthcare Q308EarningsRemarks
tenet healthcare Q308EarningsRemarks
finance42
 
TenetQ206PreparedRemarks
TenetQ206PreparedRemarksTenetQ206PreparedRemarks
TenetQ206PreparedRemarks
finance42
 
quest diagnostics 10_19transcriptforweb
quest diagnostics 10_19transcriptforwebquest diagnostics 10_19transcriptforweb
quest diagnostics 10_19transcriptforweb
finance34
 
TenetQ207PreparedRemarks
TenetQ207PreparedRemarksTenetQ207PreparedRemarks
TenetQ207PreparedRemarks
finance42
 
TenetQ406PreparedRemarks
TenetQ406PreparedRemarksTenetQ406PreparedRemarks
TenetQ406PreparedRemarks
finance42
 
quest diagnostics calltranscript7-26-06
quest diagnostics calltranscript7-26-06quest diagnostics calltranscript7-26-06
quest diagnostics calltranscript7-26-06
finance34
 
quest diagnostics 7_24_07DGXQ22007CallTranscriptforweb
quest diagnostics 7_24_07DGXQ22007CallTranscriptforwebquest diagnostics 7_24_07DGXQ22007CallTranscriptforweb
quest diagnostics 7_24_07DGXQ22007CallTranscriptforweb
finance34
 
quest diagnostics Script_07_2008
quest diagnostics Script_07_2008quest diagnostics Script_07_2008
quest diagnostics Script_07_2008
finance34
 
tenet healthcare EarningsPreparedRemarks
tenet healthcare EarningsPreparedRemarkstenet healthcare EarningsPreparedRemarks
tenet healthcare EarningsPreparedRemarks
finance42
 
quest diagnostics Q1_06_script
quest diagnostics Q1_06_scriptquest diagnostics Q1_06_script
quest diagnostics Q1_06_script
finance34
 
Hospital Financial Analysis
Hospital Financial AnalysisHospital Financial Analysis
Hospital Financial Analysis
Debbie Fernando
 
TenetQ107PreparedRemarks
TenetQ107PreparedRemarksTenetQ107PreparedRemarks
TenetQ107PreparedRemarks
finance42
 
TenetQ306PreparedRemarks1
TenetQ306PreparedRemarks1TenetQ306PreparedRemarks1
TenetQ306PreparedRemarks1
finance42
 
cardinal health Q1 2008 Earnings Transcript
cardinal health  	Q1 2008 Earnings Transcriptcardinal health  	Q1 2008 Earnings Transcript
cardinal health Q1 2008 Earnings Transcript
finance2
 
quest diagnostics q1 2005
quest diagnostics q1 2005quest diagnostics q1 2005
quest diagnostics q1 2005
finance34
 
3m Transcript 2006 1st
3m Transcript 2006 1st3m Transcript 2006 1st
3m Transcript 2006 1st
finance10
 

Similar to TenetQ106PreparedRemarks (20)

tenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarkstenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarks
 
tenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarkstenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarks
 
tenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarkstenet healthcare QuarterEndedDecember312008PreparedRemarks
tenet healthcare QuarterEndedDecember312008PreparedRemarks
 
TenetQ307PreparedRemarks_Final
TenetQ307PreparedRemarks_FinalTenetQ307PreparedRemarks_Final
TenetQ307PreparedRemarks_Final
 
tenet healthcare Q308EarningsRemarks
tenet healthcare Q308EarningsRemarkstenet healthcare Q308EarningsRemarks
tenet healthcare Q308EarningsRemarks
 
TenetQ206PreparedRemarks
TenetQ206PreparedRemarksTenetQ206PreparedRemarks
TenetQ206PreparedRemarks
 
quest diagnostics 10_19transcriptforweb
quest diagnostics 10_19transcriptforwebquest diagnostics 10_19transcriptforweb
quest diagnostics 10_19transcriptforweb
 
TenetQ207PreparedRemarks
TenetQ207PreparedRemarksTenetQ207PreparedRemarks
TenetQ207PreparedRemarks
 
TenetQ406PreparedRemarks
TenetQ406PreparedRemarksTenetQ406PreparedRemarks
TenetQ406PreparedRemarks
 
quest diagnostics calltranscript7-26-06
quest diagnostics calltranscript7-26-06quest diagnostics calltranscript7-26-06
quest diagnostics calltranscript7-26-06
 
quest diagnostics 7_24_07DGXQ22007CallTranscriptforweb
quest diagnostics 7_24_07DGXQ22007CallTranscriptforwebquest diagnostics 7_24_07DGXQ22007CallTranscriptforweb
quest diagnostics 7_24_07DGXQ22007CallTranscriptforweb
 
quest diagnostics Script_07_2008
quest diagnostics Script_07_2008quest diagnostics Script_07_2008
quest diagnostics Script_07_2008
 
tenet healthcare EarningsPreparedRemarks
tenet healthcare EarningsPreparedRemarkstenet healthcare EarningsPreparedRemarks
tenet healthcare EarningsPreparedRemarks
 
quest diagnostics Q1_06_script
quest diagnostics Q1_06_scriptquest diagnostics Q1_06_script
quest diagnostics Q1_06_script
 
Hospital Financial Analysis
Hospital Financial AnalysisHospital Financial Analysis
Hospital Financial Analysis
 
TenetQ107PreparedRemarks
TenetQ107PreparedRemarksTenetQ107PreparedRemarks
TenetQ107PreparedRemarks
 
TenetQ306PreparedRemarks1
TenetQ306PreparedRemarks1TenetQ306PreparedRemarks1
TenetQ306PreparedRemarks1
 
cardinal health Q1 2008 Earnings Transcript
cardinal health  	Q1 2008 Earnings Transcriptcardinal health  	Q1 2008 Earnings Transcript
cardinal health Q1 2008 Earnings Transcript
 
quest diagnostics q1 2005
quest diagnostics q1 2005quest diagnostics q1 2005
quest diagnostics q1 2005
 
3m Transcript 2006 1st
3m Transcript 2006 1st3m Transcript 2006 1st
3m Transcript 2006 1st
 

More from finance42

saic annual reports 2003
saic annual reports 2003saic annual reports 2003
saic annual reports 2003
finance42
 
saic annual reports 2005
saic annual reports 2005saic annual reports 2005
saic annual reports 2005
finance42
 
saic annual reports 2006
saic annual reports 2006saic annual reports 2006
saic annual reports 2006
finance42
 
saic annual reports 2007
saic annual reports 2007saic annual reports 2007
saic annual reports 2007
finance42
 
saic annual reports 2008
saic annual reports 2008saic annual reports 2008
saic annual reports 2008
finance42
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808
finance42
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808
finance42
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808
finance42
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808
finance42
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008
finance42
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508
finance42
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508
finance42
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conf
finance42
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008
finance42
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conf
finance42
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
finance42
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
finance42
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508
finance42
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508
finance42
 
terex Citi072508
terex Citi072508terex Citi072508
terex Citi072508
finance42
 

More from finance42 (20)

saic annual reports 2003
saic annual reports 2003saic annual reports 2003
saic annual reports 2003
 
saic annual reports 2005
saic annual reports 2005saic annual reports 2005
saic annual reports 2005
 
saic annual reports 2006
saic annual reports 2006saic annual reports 2006
saic annual reports 2006
 
saic annual reports 2007
saic annual reports 2007saic annual reports 2007
saic annual reports 2007
 
saic annual reports 2008
saic annual reports 2008saic annual reports 2008
saic annual reports 2008
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conf
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conf
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508
 
terex Citi072508
terex Citi072508terex Citi072508
terex Citi072508
 

Recently uploaded

Role of Information Technology in Revenue - Prof Oyedokun.pptx
Role of Information Technology in Revenue  - Prof Oyedokun.pptxRole of Information Technology in Revenue  - Prof Oyedokun.pptx
Role of Information Technology in Revenue - Prof Oyedokun.pptx
Godwin Emmanuel Oyedokun MBA MSc PhD FCA FCTI FCNA CFE FFAR
 
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...
Vighnesh Shashtri
 
Who Is Abhay Bhutada, MD of Poonawalla Fincorp
Who Is Abhay Bhutada, MD of Poonawalla FincorpWho Is Abhay Bhutada, MD of Poonawalla Fincorp
Who Is Abhay Bhutada, MD of Poonawalla Fincorp
beulahfernandes8
 
一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理
一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理
一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理
obyzuk
 
OAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptx
OAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptxOAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptx
OAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptx
hiddenlevers
 
when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.
DOT TECH
 
2. Elemental Economics - Mineral demand.pdf
2. Elemental Economics - Mineral demand.pdf2. Elemental Economics - Mineral demand.pdf
2. Elemental Economics - Mineral demand.pdf
Neal Brewster
 
The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...
The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...
The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...
muslimdavidovich670
 
Earn a passive income with prosocial investing
Earn a passive income with prosocial investingEarn a passive income with prosocial investing
Earn a passive income with prosocial investing
Colin R. Turner
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
DOT TECH
 
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdfBONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
coingabbar
 
5 Tips for Creating Standard Financial Reports
5 Tips for Creating Standard Financial Reports5 Tips for Creating Standard Financial Reports
5 Tips for Creating Standard Financial Reports
EasyReports
 
How Non-Banking Financial Companies Empower Startups With Venture Debt Financing
How Non-Banking Financial Companies Empower Startups With Venture Debt FinancingHow Non-Banking Financial Companies Empower Startups With Venture Debt Financing
How Non-Banking Financial Companies Empower Startups With Venture Debt Financing
Vighnesh Shashtri
 
how to sell pi coins effectively (from 50 - 100k pi)
how to sell pi coins effectively (from 50 - 100k  pi)how to sell pi coins effectively (from 50 - 100k  pi)
how to sell pi coins effectively (from 50 - 100k pi)
DOT TECH
 
An Overview of the Prosocial dHEDGE Vault works
An Overview of the Prosocial dHEDGE Vault worksAn Overview of the Prosocial dHEDGE Vault works
An Overview of the Prosocial dHEDGE Vault works
Colin R. Turner
 
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...
sameer shah
 
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
otogas
 
where can I find a legit pi merchant online
where can I find a legit pi merchant onlinewhere can I find a legit pi merchant online
where can I find a legit pi merchant online
DOT TECH
 
G20 summit held in India. Proper presentation for G20 summit
G20 summit held in India. Proper presentation for G20 summitG20 summit held in India. Proper presentation for G20 summit
G20 summit held in India. Proper presentation for G20 summit
rohitsaxena882511
 
SWAIAP Fraud Risk Mitigation Prof Oyedokun.pptx
SWAIAP Fraud Risk Mitigation   Prof Oyedokun.pptxSWAIAP Fraud Risk Mitigation   Prof Oyedokun.pptx
SWAIAP Fraud Risk Mitigation Prof Oyedokun.pptx
Godwin Emmanuel Oyedokun MBA MSc PhD FCA FCTI FCNA CFE FFAR
 

Recently uploaded (20)

Role of Information Technology in Revenue - Prof Oyedokun.pptx
Role of Information Technology in Revenue  - Prof Oyedokun.pptxRole of Information Technology in Revenue  - Prof Oyedokun.pptx
Role of Information Technology in Revenue - Prof Oyedokun.pptx
 
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...
 
Who Is Abhay Bhutada, MD of Poonawalla Fincorp
Who Is Abhay Bhutada, MD of Poonawalla FincorpWho Is Abhay Bhutada, MD of Poonawalla Fincorp
Who Is Abhay Bhutada, MD of Poonawalla Fincorp
 
一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理
一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理
一比一原版(GWU,GW毕业证)加利福尼亚大学|尔湾分校毕业证如何办理
 
OAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptx
OAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptxOAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptx
OAT_RI_Ep20 WeighingTheRisks_May24_Trade Wars.pptx
 
when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.
 
2. Elemental Economics - Mineral demand.pdf
2. Elemental Economics - Mineral demand.pdf2. Elemental Economics - Mineral demand.pdf
2. Elemental Economics - Mineral demand.pdf
 
The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...
The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...
The WhatsPump Pseudonym Problem and the Hilarious Downfall of Artificial Enga...
 
Earn a passive income with prosocial investing
Earn a passive income with prosocial investingEarn a passive income with prosocial investing
Earn a passive income with prosocial investing
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
 
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdfBONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
 
5 Tips for Creating Standard Financial Reports
5 Tips for Creating Standard Financial Reports5 Tips for Creating Standard Financial Reports
5 Tips for Creating Standard Financial Reports
 
How Non-Banking Financial Companies Empower Startups With Venture Debt Financing
How Non-Banking Financial Companies Empower Startups With Venture Debt FinancingHow Non-Banking Financial Companies Empower Startups With Venture Debt Financing
How Non-Banking Financial Companies Empower Startups With Venture Debt Financing
 
how to sell pi coins effectively (from 50 - 100k pi)
how to sell pi coins effectively (from 50 - 100k  pi)how to sell pi coins effectively (from 50 - 100k  pi)
how to sell pi coins effectively (from 50 - 100k pi)
 
An Overview of the Prosocial dHEDGE Vault works
An Overview of the Prosocial dHEDGE Vault worksAn Overview of the Prosocial dHEDGE Vault works
An Overview of the Prosocial dHEDGE Vault works
 
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...
 
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
 
where can I find a legit pi merchant online
where can I find a legit pi merchant onlinewhere can I find a legit pi merchant online
where can I find a legit pi merchant online
 
G20 summit held in India. Proper presentation for G20 summit
G20 summit held in India. Proper presentation for G20 summitG20 summit held in India. Proper presentation for G20 summit
G20 summit held in India. Proper presentation for G20 summit
 
SWAIAP Fraud Risk Mitigation Prof Oyedokun.pptx
SWAIAP Fraud Risk Mitigation   Prof Oyedokun.pptxSWAIAP Fraud Risk Mitigation   Prof Oyedokun.pptx
SWAIAP Fraud Risk Mitigation Prof Oyedokun.pptx
 

TenetQ106PreparedRemarks

  • 1. Tenet’s Q1 2006 Earnings Call Prepared Remarks May 9, 2006 Trevor Fetter, President & Chief Executive Officer Thank you, operator, and good morning everyone. I trust that you’ve had an opportunity to review the press release we issued this morning with our first quarter results. I’ll start by giving you an overview of the quarter, and then our Chief Operating Officer, Reynold Jennings, will provide some commentary on volumes. I hope that you’ve seen our press release regarding the action yesterday evening by the Inspector General of HHS to exclude our hospital in San Diego from federal health programs. The IG made that announcement after we had prepared our remarks for this morning, but Peter Urbanowicz, our General Counsel, and I will be prepared to answer your questions about that matter during our Q&A. The predominant themes in the quarter continued to be weak volumes, strong pricing and good cost control. Three years ago, we had isolated but severe problems in pricing and clinical quality, and we had widespread problems in cost control, litigation, investigations, governance, labor relations and relations with uninsured patients. Since that time, we’ve either resolved, or are far along in resolving, each one of those issues. But as we’ve been fixing the original problems, we’ve confronted two new challenges affecting the entire industry: bad debts and weak volumes. Today, bad debts appear to be stabilizing, while weak volumes remain our number one concern. As we worked to resolve the problems that we faced three years ago, we built a solid foundation for the future. We are fighting the volume challenge with the same energy and creativity that we brought to the problems we faced at the end of 2002, and our success in these areas demonstrates that when our team sets out to fix something, we fix it. I am confident that we will do the same with volumes. Let me turn to the results for the quarter. We generated net income from continuing operations of $15 million, or 3 cents per share, and EBITDA of $216 million for the quarter, for a margin of 8.9 percent. We use two different metrics to describe results in our earnings release: continuing operations and same-hospital. Both measures are important, but I’m going to refer primarily to same- 1
  • 2. hospital numbers in my comments, as I believe those are the greatest interest to you. Same- hospital numbers are continuing operations excluding the six hospitals impacted by Hurricane Katrina. Operations in the Gulf Coast region are still sufficiently impaired that to include them in the discussion distorts the performance of our core business. On a same-hospital basis, our EBITDA margin was 9.5 percent, a 50 basis point increase from last year’s first quarter. We identified five distinct items in our press release that had a net favorable contribution of $1 million. We broke these out so that you could decide which of these items should be included in your individual assessments of our current earnings. These items include litigation and investigation costs, impairment and restructuring charges, costs related to Katrina, our unusual tax position and favorable adjustments from prior year cost report settlements. As we have discussed in previous quarters, we also had a reversal of some temporary spikes in bad debt expense from the last half of ’05, which we estimate added about $5 million, or 1 cent per share, to earnings this quarter. I’ll take you through the details on bad debt trends in just a few minutes. As you know, the first quarter is typically our strongest of the year. The 3 cents we earned from continuing operations is above the consensus estimates for the quarter, but at this point, we are not going to refine or confirm the outlook for 2006 that we issued in March. Our practice has been to issue an outlook only once a year, and after only one quarter it would be premature to refine or confirm it. Drilling down into the specifics of the quarter, let’s start with volumes. The decline in volumes drives the outcome of virtually every other performance metric, and starting with volumes is the only way to place the quarter’s results in context. Same-hospital admissions declined by 3.3 percent relative to last year’s first quarter. Nearly a third of the decline results from the deliberate elimination of service lines or operating entities. The more serious impact on earnings came from the 5.3 percent decline in same-hospital commercial managed care volumes. Our acuity rose by one and a quarter percent from last year’s first quarter, and by more than a half a percent from Q405. This was driven by increases in acuity in several of our service lines. In cardiology, we had volume losses in the less intense procedures. Cardiology volume was down 5 percent, but case mix was flat. In orthopedic and spine surgery, volumes were up by nearly 3 percent and case mix was up 2 percent. In pulmonary medicine, volume was down by 6 percent, but case mix was up by 6 percent. And in general surgery, volume was down by 4 percent and case mix was up 2 percent. These were the drivers of the increase in acuity for the quarter. Let’s turn to pricing, where we achieved very strong results for the third consecutive quarter. We recorded a 7.7 percent increase in same-hospital, Compact-adjusted net inpatient revenue per admission. On the outpatient side, the comparable metric increased by 11.9 percent. While the 2
  • 3. increase in acuity helped slightly, these aggregate increases are especially impressive as they helped offset the adverse shift in our payor mix away from commercial managed care patients and toward managed Medicare and Medicaid. The real strength becomes visible when we narrow our focus to just the commercial managed care piece of our business. For commercial managed care, net inpatient revenue per admission increased by 11.8 percent on a same-hospital basis. Our managed care team has done an excellent job of fixing our pricing problems and putting our hospitals on solid ground in pricing and contract terms. The missing piece is volume, and that’s why Tenet’s profit growth is critically dependent on volume growth. When we rebuild commercial managed care volumes, these impressive pricing gains will be reflected on the bottom line. If we had generated the same commercial managed care volumes in the first quarter of 2006 as in the first quarter of 2005, we would have retained additional revenues of about $50 million with 50 to 60 percent of that adding to EBITDA for the quarter. We estimate that retaining the managed care volume we lost over the past year would have added 110 to 125 basis points to our EBITDA margin. Despite the recent declining volumes in commercial managed care, our aggregate portfolio yield on our inpatient business increased by 6.1 percent compared to the first quarter of 2005. You will recall that in our fourth quarter, we reported a year-over-year increase of 9.7 percent for our aggregate portfolio yield; so on a sequential basis, our improvement moderated a bit. We expect the moderation to continue as we reach the anniversary of some of these strong quarters. These pricing increases offset the volume declines to create 3.1 percent growth in revenues on a same-hospital, Compact-adjusted basis. We also continued to do a great job on cost control. Same-hospital controllable costs per adjusted patient day actually declined by 2.8 percent from Q405 to Q106. On a year-over-year basis, our controllable operating expense per adjusted patient day rose by 5.2 percent. Not surprisingly, the line item with the greatest increase was supply expense, which increased 6.2 percent. Despite a comparatively more severe decline in volumes, our growth rate in unit controllable costs of 5.2 percent is below our peers and further demonstrates the favorable impact of our discipline in cost control, which is now hard-wired throughout the company. Given what we’ve accomplished in pricing and costs, we’ve set the stage for strong growth in income when we generate growth in volumes. Let’s move on to bad debt. On a same-hospital, Compact-adjusted basis, our bad debt ratio was 12.9 percent for the quarter, an increase of 110 basis points from a year ago, but a decline of 140 basis points from the 14.3 percent that we reported last quarter. 3
  • 4. You will recall that in the past two quarters we isolated the impact of some systems conversion issues, which caused a temporary increase in bad debt expense. We told you that as we collected these delayed billings, we expected our bad debt ratio to show a temporary decline, reversing the earlier increase. This quarter we collected the remainder of these amounts, which reduced the first quarter’s bad debt ratio by roughly 20 basis points, adding an estimated $5 million to EBITDA. Another trend in bad debt was that more of our uninsured patients were classified as “charity.” In part, this is due to the elimination of the adult medically indigent program in Tennessee and the elimination of funding for undocumented immigrants in the California county where Doctors Medical Center of Modesto is located. The elimination or reduction of similar funds in Missouri and Georgia will continue to limit the uninsured, low income population from eligibility and further increase our charity care. I am highlighting this growth in charity partly because I don’t want anyone to conclude that we are making more progress on reducing bad debt than is actually the case. The other reason to highlight this change is to follow up on my comments last quarter about cost-shifting. Last quarter, I talked about cost-shifting from employer to employee. Well, here’s another stark example of cost shifting: state and county governments simply deciding not to compensate hospitals for the care that we are providing to their residents, whom we have a federal mandate to care for. I think it’s outrageous, and you’ve got to wonder when this situation is going to reach a breaking point. The number of charity inpatients increased by 30 percent from last year’s first quarter, on a same-hospital basis to over 2,800 patients. Total uncompensated inpatient care volume, defined as uninsured self pay and charity, rose 8 percent on a same-hospital basis since the first quarter of last year. It’s a rough estimate, but we think that the total uncompensated care that we provide these people is costing us about a quarter billion dollars per year. That’s cost, not charges or foregone revenues, which of course, would be considerably higher. Since hospitals are the primary sector of the health care economy that is bearing the responsibility for these costs, again I’ve got to ask the question of when this situation reaches a breaking point and gains sufficient attention in federal, state and local governments. We also had a very active quarter on the quality front. The major national managed care companies recognized Tenet’s advances in quality by continuing to award our hospitals’ Centers of Excellence designations for an ever-growing number of service lines. Last quarter, we spoke in great detail about the UnitedHealth Care designations. This quarter, I’d like to spend some time telling you about our Cigna designations. Cigna’s policy is to re-evaluate all service line designations on an annual basis. This year, they expanded the number of service lines to 29 from 19, while simultaneously raising the volumes required to be eligible. 4
  • 5. In 2005, 41 Tenet hospitals earned 95 service line designations as Centers of Excellence from Cigna. As of today, Tenet hospitals had achieved a 56 percent increase in Centers of Excellence designations, bringing our total Cigna designations to 149. To receive these designations requires the hospitals to receive 3 stars from Cigna on both patient outcomes and cost efficiency, offering significant advantages to both the patient and the payor. In addition to these designations, 11 of our hospitals were named Cigna Certified Hospitals for Bariatric Surgery. Because Cigna awarded only 88 of these certifications across the country, Tenet’s hospitals represent one-eighth of the national total. We hope that these certifications, along with the government’s recent decision to cover some bariatric procedures, will influence other payors to cover these surgeries going forward. We’ve got a number of initiatives to improve quality and grow volume. Our efforts to gain these Centers of Excellence designations are at the heart of these strategies. To benefit from the cost efficiencies associated with these designations, some of the managed care payors are offering to reduce deductibles or eliminate co-pays. When you factor these incentives into the equation, the ability to link quality and efficiency to higher patient volumes becomes very real and very exciting. Two and a half years ago, I declared that quality would be our strategy because it was the right thing to do. Period. But as these quality designations and plan designs intersect with consumerism, Tenet’s investments in quality should show greater economic returns as well. Let’s now turn to cash flow. Cash flow used by operating activities was negative $321 million in the quarter. Including capital expenditures of $117 million, free cash flow was negative $438 million. While our cash consumption was large, it’s important to note that there were several unusual items adversely impacting cash this quarter: First, payments toward restructuring, litigation costs and settlements, and discontinued operations totaled $183 million. This includes a $145 million payment to settle a securities class action lawsuit and a $7 million payment to settle with Florida’s attorney general. Second, we paid $97 million in the quarter to fund the entire 2005 401(k) matching contributions. This is substantially more than we paid a year ago because the Q105 funding represented only half the total 2004 contribution. We decided to change the timing of our funding in May 2004 for contributions for the period beginning July 1, 2004, which were then funded in the first quarter of 2005. We made this change to reduce costs and we estimate this change will save us nearly $15-20 million annually, due to employee turnover and eligibility. Third, our interest payments on long-term debt were $123 million. There were additional payments of $29 million this quarter compared to the prior year due to the additional debt that we issued in January 2005 and the timing of our interest payments. 5
  • 6. The first quarter typically has a high cash burn, given the timing of our expenditures. If you look at 2005, for example, you’ll see that cash flow improved in subsequent quarters during the year. Unrestricted net cash at the end of March was $975 million. In addition, we had another $263 million in cash that’s restricted as collateral for standby letters of credit. Now, before I turn the floor over to Reynold, I’d like to call your attention to a series of organizational changes that we’ve made over the past few weeks. We appointed one of our senior operations executives to lead a group to execute our outpatient growth strategy. We also restructured our regional operations in Florida and the Southern States to better enable our regional leaders to focus on local market business development. I’m proud that we have been able to retain and recognize talented people from within the organization, and we’ve been able to recruit fresh talent from other fine companies. With that as an overview, let me turn things over to Reynold for a deeper look at some of the volume building efforts underway in our hospitals. Reynold Jennings, Chief Operating Officer Thanks Trevor, and good morning. I’d like to begin by commenting on Tenet’s inpatient volumes in the first quarter. As Trevor mentioned, we saw a continuation of the aggregate volume decline we’ve experienced in recent quarters. Embedded in these numbers, however, is a more complex and positive story. Fifteen of our hospitals actually had strong year-over-year growth in patient volumes. And 11 more had volumes about even with their first-quarter results last year. In other words, 26 hospitals – or about 40 percent of our portfolio – delivered reasonably good results in the quarter. The hospitals with the strongest growth were in Birmingham, Atlanta, Omaha, St. Louis, Memphis, the Carolinas and parts of Florida. Since many of these are historically among our strongest margin hospitals, we see this as good news. On the other side of the coin, 14 of our hospitals – or about 20 percent of the portfolio – accounted for about 90 percent of our aggregate, year-over-year decline in volumes. This group included hospitals in Florida, California and Texas. Let me give you some detail about what affected these hospitals in the quarter: A. In Florida, the combination of a warm winter in the Northeast, and extensive damage from Hurricane Wilma seriously reduced tourism in the state, as well as the number of snowbirds who usually spend the winter there. These factors, along with a weaker than normal flu season, resulted in fewer admissions at five of our Florida hospitals. Also, hurricane damage to condo projects forced some, mostly elderly residents who live in the communities served by two of our hospitals, to find temporary housing outside the area. However, we believe that situation will reverse itself shortly. 6
  • 7. B. In California, our targeted growth initiative’s planned de-emphasis of certain service lines accounted for about half of the volume decline there. We attribute the other half to our decision at two California hospitals to reject the unacceptably low capitation rates in a new contract offered by two large medical groups. C. In Texas, two hospitals we lease in Dallas accounted for 24 percent of the volume decline in that state. Business at those hospitals – Trinity and RHD Memorial – has been hurt this year by the uncertainty generated after their owner, the Metrocrest Hospital Authority, sought competitive bids to manage them once our lease expires in 2007. The balance of our volume decline in Texas was primarily the result of stiff competition from four new and maturing hospitals in Dallas and Houston. So, to summarize, I’d say our volume results for the first quarter show that a significant portion of our portfolio is doing pretty well, especially in light of the general challenges faced by all hospitals these days. Our overall volume weakness is basically caused by 14 hospitals with very specific issues, and we are aggressively tackling those situations. Let me now move to our Physician Sales and Service Program, which we launched last year. The results continue to be very encouraging. Our hospital management teams have had face-to- face meetings with about 11,000 of our 13,000 targeted doctors, and as a result, we have identified about 1,600 individual opportunities for service improvement at our hospitals. Based on this experience, we’ve learned that there is nothing more positive in building and cementing relationships with our doctors than asking them to tell us about issues they have with the hospital and then taking quick action to resolve them. The physicians continue to express appreciation for the visits by our local hospital management teams and the efforts being made to respond to their needs. On our last call, I gave you some examples of the service improvement opportunities we have identified, all of which fall into three categories: First, those that are easy to understand and resolve; second, those that can be resolved but will take some time; and thirdly, those for which we don’t yet have a solution. Thematically, these opportunities fall into seven broad categories: 1. Process improvement and throughput 2. Customer service 3. Modernization of our physical plants 4. Marketing/advertising/community outreach 5. Physician recruitment 6. Effective communication between hospital administrators and physicians, and 7. Scheduling, registration and pricing of outpatient services Some components of our Commitment to Quality initiative are already implementing significant improvements in critical service areas such as the emergency department and surgery. With the 7
  • 8. additional information we now have as a result our physician visits, we are focused on improving others areas within the hospital and also boosting the spirit of collaboration with our physicians. With regard to boosting that spirit of collaboration, let me give you three rather simple examples: • First, physicians in one of our Houston hospitals told us that our outpatient order forms were difficult to use. We immediately worked with the physicians to redesign the forms and added carbonless copies to save both time and cost. • Second, physicians in East Texas told us that a specialty group at a competing hospital was breaking up, and that gave our hospital leaders the opportunity to recruit two of those physicians to our hospital. • And third, we found that the primary care physicians and endocrinologists in our El Paso hospitals were looking for educational opportunities in bariatric surgery. They were delighted when we quickly gave them copies of our new clinical service manual focused specifically on bariatric procedures. These examples should make it clear that not all physician-friendly improvements need to be expensive. And, as an indication of how well our hospital managers are embracing the value of the physician visitation program, I can tell you that our data clearly shows the hospitals with the greatest volume challenges also happen to be the ones most actively using the program software tracking tool that we’ve implemented. I’m optimistic that we have much more value to harvest from this program. Now let me talk about the operational effect of local hospital management stability. Of the 14 hospitals I spoke of that drove the lion’s share of our aggregate volume decline in the first quarter, three were being managed by an interim chief executive officer and three others were being managed by newly hired permanent CEOs. We lost six experienced hospital CEOs in December 2005, all of whom left because they had been recruited by larger, well-known hospital systems. I see that loss as a bittersweet consequence of our accomplishments in public quality scores, cost control and data-enriched decision making. Tenet’s progress in these and other operational enhancement initiatives have made many of our hospital executives the target of executive search firms. We are redoubling our efforts to retain our top talent, and one way we’re doing that is by making sure our experienced hospital CEOs have a career ladder with us. Fortunately, we have been able to replace our hospital departing hospital executives with well-qualified internal candidates in almost half the cases. In addition, our external recruiting efforts have brought us some very good managers from other companies and hospital systems. I am excited about both the internal and external candidates’ enthusiasm for being a part of our future. Before I turn it back over to Trevor, let me mention that at the end of the first quarter we had virtually completed the latest wave of our targeted growth initiative. This involved eleven hospitals, including the remaining two in California, five in Florida, two in the Central Northeast, and two in Texas. 8
  • 9. With that, I’ll hand it back over to Trevor. Trevor Fetter, President & Chief Executive Officer Thank you Reynold, operator, we are ready now to begin the Q&A. [END] 9